Investor Relations

Investor Overview
Corporate Governance
Stock Information
How to Vote
SEC Filings
News
Presentations & Events
Information Request
FAQs

Presentations & Events

Select Year
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Presentations
Presentation

Paratek Corporate Presentation

Summer 2023
2023
Presentations
Presentation
Webcasts
Webcast

Paratek Pharmaceuticals Q1 2023 Earnings Conference Call

May 2023
2023
Presentations
Presentation
Webcasts
Webcast

Paratek Pharmaceuticals FY 2022 Earnings Conference Call

March 2023
2023
Presentations
Presentation

Paratek Corporate Presentation

Spring 2023
2023
Presentations
Presentation

Paratek Corporate Presentation

Winter 2022
2022
Webcasts
Webcast

Paratek Pharmaceuticals Presents at Credit Suisse 31st Annual Healthcare Conference

November 2022
2022
Presentations
Presentation
Webcasts
Webcast

Paratek Pharmaceuticals Q3 2022 Earnings Conference Call

November 2022
2022
Presentations
Presentation
Webcasts
Webcast

Paratek Pharmaceuticals hosts Investor Update on the Global Opportunity in Non-Tuberculous Mycobacteria (NTM)

October 2022
2022
Presentations
Presentation
Webcasts
Webcast

Paratek Pharmaceuticals Q2 2022 Earnings Conference Call

August 2022
2022
Events
Event
Presentations
Presentation
Webcasts
Webcast

Paratek Pharmaceuticals to Report First Quarter Financial Results on May 4, 2022

May 2022
2022
Events
Event
Presentations
Presentation
Webcasts
Webcast

Paratek Pharmaceuticals to Report Fourth Quarter and Full Year 2021 Financial Results on March 14, 2022

March 2022
2022
Events
Event
Presentations
Presentation
Webcasts
Webcast

Paratek Pharmaceuticals to Report Third Quarter 2021 Financial Results on Nov. 8, 2021

November 2021
2021
Presentations
Presentation
Webcasts
Webcast

Paratek Pharmaceuticals Q2 2021 Earnings Conference Call

August 2021
2021
Presentations
Presentation
Webcasts
Webcast

Paratek Pharmaceuticals Corporate Update and Key Opinion Leader and Patient Advocate Presentations on Non-Tuberculous Mycobacteria, M. abscessus Webinar

June 2021
2021
Presentations
Presentation
Webcasts
Webcast

Paratek Pharmaceuticals Q1 2021 Earnings Conference Call

May 2021
2021
Press Releases
Press Release

Paratek Pharmaceuticals to Present at the 10th Annual SVB Leerink Global Healthcare Conference

February 2021
2021
Presentations
Presentation
Webcasts
Webcast

Paratek Pharmaceuticals Q4 2020 Earnings Conference Call

February 2021
2021
Press Releases
Press Release
Presentations
Presentation

Paratek Pharmaceuticals to Report Fourth Quarter and Full Year 2020 Financial Results on February 24, 2021

February 2021
2021
Press Releases
Press Release

Paratek Pharmaceuticals to Present at the 2021 H.C. Wainwright BIOCONNECT Virtual Conference

January 2021
2021
Presentations
Presentation
Webcasts
Webcast

Paratek Pharmaceuticals Inc Q3 2020 Earnings Conference Call

November 2020
2020
Press Releases
Press Release

Paratek Pharmaceuticals to Report Third Quarter 2020 Financial Results on November 5, 2020

November 2020
2020
Presentations
Presentation
Webcasts
Webcast

Paratek Pharmaceuticals to Present at Jefferies 2020 Virtual Healthcare Conference

June 2020
2020
Presentations
Presentation
Webcasts
Webcast

Paratek Pharmaceuticals to Present at Bank of America Securities 2020 Health Care Conference

May 2020
2020
Presentations
Presentation
Webcasts
Webcast

Paratek Pharmaceuticals Inc Q1 2020 Earnings Conference Call

May 2020
2020
No items found

Upcoming Events

No upcoming events currently scheduled

King of Prussia

1000 First Avenue

Suite 200

King of Prussia, PA 19406

Boston

75 Park Plaza

3rd Floor

Boston, MA 02116

617-807-6600

Recent News

View All

Privacy Policy | Terms and Conditions | Social Media Guidelines | Compliance Program |  Expanded Access Policy

© 2022 Paratek Pharmaceuticals, Inc. All rights reserved. PARATEK® and the hexagon logo are registered trademarks of Paratek Pharmaceuticals, Inc. NUZYRA® and its design logo are registered trademarks of Paratek Pharmaceuticals, Inc.

US-COR-0049 12/20